Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
布鲁顿酪氨酸激酶抑制剂保留抗 CD19 嵌合抗原受体 T 细胞功能并重新编程 B 细胞淋巴瘤中的肿瘤微环境
期刊:Cytotherapy
影响因子:3.7
doi:10.1016/j.jcyt.2023.03.005
Wenjing Luo, Chenggong Li, Jianghua Wu, Lu Tang, Xindi Wang, Yinqiang Zhang, Zhuolin Wu, Zhongpei Huang, Jia Xu, Yun Kang, Wei Xiong, Jun Deng, Yu Hu, Heng Mei